Literature DB >> 24100946

The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus.

Daniele De Luca1, Marco Piastra, Giovanna Chidini, Pierre Tissieres, Edoardo Calderini, Sandrine Essouri, Alberto Medina Villanueva, Ana Vivanco Allende, Marti Pons-Odena, Luis Perez-Baena, Michael Hermon, Ascanio Tridente, Giorgio Conti, Massimo Antonelli, Martin Kneyber.   

Abstract

PURPOSE: A new acute respiratory distress syndrome (ARDS) definition has been recently issued: the so-called Berlin definition (BD) has some characteristics that could make it suitable for pediatrics. The European Society for Pediatric Neonatal Intensive Care (ESPNIC) Respiratory Section started a project to evaluate BD validity in early childhood. A secondary aim was reaching a consensus on clinical tools (risk factors list and illustrative radiographs) to help the application of BD.
METHODS: This was an international, multicenter, retrospective study enrolling 221 children [aged greater than 30 days and less than 18 months; median age 6 (range 2-13) months], admitted to seven European pediatric intensive care units (PICU) with acute lung injury (ALI) or ARDS diagnosed with the earlier definition.
RESULTS: Patients were categorized according to the two definitions, as follows: ALI, 36; ARDS, 185 (for the American-European Consensus Conference (AECC) definition); mild, 36; moderate, 97; severe ARDS, 88 (for BD). Mortality (13.9 % for mild ARDS; 11.3 % for moderate ARDS; 25 % for severe ARDS, p = 0.04) and the composite outcome extracorporeal membrane oxygenation (ECMO)/mortality (13.9 % for mild ARDS; 11.3 % for moderate ARDS; 28.4 % for severe ARDS, p < 0.01) were different across the BD classes, whereas they were similar using the previous definition. Mortality [HR 2.7 (95 % CI 1.1-7.1)] and ECMO/mortality [HR 3 (95 % CI 1.1-7.9)] were increased only for the severe ARDS class and remained significant after adjustment for confounding factors. PICU stay was not different across severity classes, irrespective of the definition used. There was significant concordance between raters evaluating radiographs [ICC 0.6 (95 % CI 0.2-0.8)] and risk factors [ICC 0.92 (95 % CI 0.8-0.97)].
CONCLUSIONS: BD validity for children is similar to that already reported in adults and mainly due to the introduction of a "severe ARDS" category. We provided clinical tools to use BD for clinical practice, research, and health services planning in pediatric critical care.

Entities:  

Mesh:

Year:  2013        PMID: 24100946     DOI: 10.1007/s00134-013-3110-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  26 in total

Review 1.  The design of future pediatric mechanical ventilation trials for acute lung injury.

Authors:  Robinder G Khemani; Christopher J L Newth
Journal:  Am J Respir Crit Care Med       Date:  2010-08-23       Impact factor: 21.405

2.  ARDS: a clinicopathological confrontation.

Authors:  Quentin de Hemptinne; Myriam Remmelink; Serge Brimioulle; Isabelle Salmon; Jean-Louis Vincent
Journal:  Chest       Date:  2008-12-31       Impact factor: 9.410

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

4.  Acute respiratory distress in adults.

Authors:  D G Ashbaugh; D B Bigelow; T L Petty; B E Levine
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

5.  Pediatric Acute Lung Injury Epidemiology and Natural History study: Incidence and outcome of the acute respiratory distress syndrome in children.

Authors:  Yolanda López-Fernández; Amelia Martínez-de Azagra; Pedro de la Oliva; Vicent Modesto; Juan I Sánchez; Julio Parrilla; María José Arroyo; Susana Beatriz Reyes; Martí Pons-Ódena; Jesús López-Herce; Rosa Lidia Fernández; Robert M Kacmarek; Jesús Villar
Journal:  Crit Care Med       Date:  2012-12       Impact factor: 7.598

6.  Interobserver variability in applying a radiographic definition for ARDS.

Authors:  G D Rubenfeld; E Caldwell; J Granton; L D Hudson; M A Matthay
Journal:  Chest       Date:  1999-11       Impact factor: 9.410

Review 7.  The physiological basis of respiratory support.

Authors:  T Nicolai
Journal:  Paediatr Respir Rev       Date:  2006-06-02       Impact factor: 2.726

8.  Incidence of acute respiratory distress syndrome in German children and adolescents: a population-based study.

Authors:  Lutz Bindl; Katja Dresbach; Michael J Lentze
Journal:  Crit Care Med       Date:  2005-01       Impact factor: 7.598

9.  The Berlin definition of ARDS: an expanded rationale, justification, and supplementary material.

Authors:  Niall D Ferguson; Eddy Fan; Luigi Camporota; Massimo Antonelli; Antonio Anzueto; Richard Beale; Laurent Brochard; Roy Brower; Andrés Esteban; Luciano Gattinoni; Andrew Rhodes; Arthur S Slutsky; Jean-Louis Vincent; Gordon D Rubenfeld; B Taylor Thompson; V Marco Ranieri
Journal:  Intensive Care Med       Date:  2012-08-25       Impact factor: 17.440

10.  Acute respiratory distress syndrome: the Berlin Definition.

Authors:  V Marco Ranieri; Gordon D Rubenfeld; B Taylor Thompson; Niall D Ferguson; Ellen Caldwell; Eddy Fan; Luigi Camporota; Arthur S Slutsky
Journal:  JAMA       Date:  2012-06-20       Impact factor: 56.272

View more
  34 in total

1.  Are we ready to accept the Berlin definition of acute respiratory distress syndrome for use in children?

Authors:  Robinder G Khemani; Lincoln Smith
Journal:  Crit Care Med       Date:  2015-05       Impact factor: 7.598

2.  Evaluating the Berlin Definition in pediatric ARDS.

Authors:  Robinder G Khemani; Douglas F Wilson; Andrés Esteban; Niall D Ferguson
Journal:  Intensive Care Med       Date:  2013-10-08       Impact factor: 17.440

3.  Circulating markers of endothelial and alveolar epithelial dysfunction are associated with mortality in pediatric acute respiratory distress syndrome.

Authors:  Nadir Yehya; Neal J Thomas; Nuala J Meyer; Jason D Christie; Robert A Berg; Susan S Margulies
Journal:  Intensive Care Med       Date:  2016-04-21       Impact factor: 17.440

4.  Corticosteroids for paediatric ARDS: unjustified—even unjustifiable?

Authors:  Mark J Peters; Samiran Ray; Martin Kneyber
Journal:  Intensive Care Med       Date:  2015-07-10       Impact factor: 17.440

5.  'Lumping or splitting' in paediatric acute respiratory distress syndrome (PARDS).

Authors:  Daniele De Luca; David A Harrison; Mark J Peters
Journal:  Intensive Care Med       Date:  2018-08-24       Impact factor: 17.440

Review 6.  Definition and epidemiology of acute respiratory distress syndrome.

Authors:  Emanuele Rezoagli; Roberto Fumagalli; Giacomo Bellani
Journal:  Ann Transl Med       Date:  2017-07

7.  Acute Respiratory Distress Syndrome Following Pediatric Trauma: Application of Pediatric Acute Lung Injury Consensus Conference Criteria.

Authors:  Elizabeth Y Killien; Roel L N Huijsmans; Iesha L Ticknor; Lincoln S Smith; Monica S Vavilala; Frederick P Rivara; R Scott Watson
Journal:  Crit Care Med       Date:  2020-01       Impact factor: 7.598

8.  Pulse oximetry vs. PaO2 metrics in mechanically ventilated children: Berlin definition of ARDS and mortality risk.

Authors:  Robinder G Khemani; Sarah Rubin; Sanjay Belani; Dennis Leung; Simon Erickson; Lincoln S Smith; Jerry J Zimmerman; Christopher J L Newth
Journal:  Intensive Care Med       Date:  2014-09-18       Impact factor: 17.440

9.  Association between age and acute respiratory distress syndrome development and mortality following trauma.

Authors:  Elizabeth Y Killien; Brianna Mills; Monica S Vavilala; R Scott Watson; Grant E OʼKeefe; Frederick P Rivara
Journal:  J Trauma Acute Care Surg       Date:  2019-05       Impact factor: 3.313

Review 10.  Sepsis and Pediatric Acute Respiratory Distress Syndrome.

Authors:  Nadir Yehya; Neal J Thomas
Journal:  J Pediatr Intensive Care       Date:  2018-12-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.